Secondary Logo

Journal Logo

Articles by Christophe Renou

Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium

Pariente, Alexandre; Chazouilleres, Olivier; Causse, Xavier; More

European Journal of Gastroenterology & Hepatology. Post Author Corrections: November 30, 2020

Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients

Garioud, Armand; Heng, Ratmony; Amiot, Xavier; More

European Journal of Gastroenterology & Hepatology. 31(10):1270-1274, October 2019.

Hepatogastroenterologists’ knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey

Causse, Xavier; Cadranel, Jean-François; Potier, Pascal; More

European Journal of Gastroenterology & Hepatology. 27(5):544-549, May 2015.

A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus

Halfon, Philippe; Bourliere, Marc; Ouzan, Denis; More

European Journal of Gastroenterology & Hepatology. 23(10):931-935, October 2011.

Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in ‘true life’: a plea in favor of independent postmarketing evaluations

Pariente, Alexandre; Lahmek, Pierre; Duprat, Christel; More

European Journal of Gastroenterology & Hepatology. 22(11):1297-1302, November 2010.

Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers

Renou, Christophe; Cadranel, Jean-François; Pariente, Alexandre; More

European Journal of Gastroenterology & Hepatology. 20(12):1235-1237, December 2008.